In this study, we used MethyLight assay to evaluate the methylation level of HOXA11 promoter region in paired normal and cancer tissues as well as in matched serum samples, then determined whether methylation status is associated with clinicopathological features or disease prognosis. Here, HOXA11 is linked to cancer.